When ARHI was re-expressed in breast cancer cells treated with paclitaxel, the growth inhibitory effect of paclitaxel was enhanced by promoting autophagy, apoptosis, and G2/M cell cycle arrest. Here, DIRAS3 is linked to breast cancer.